文献速递角膜与眼表疾病青光眼眼整形与眼眶

淋巴管在眼部疾病发病机制中的新作用

The novel role of lymphatic vessels in the pathogenesis of ocular diseases.
PubMed 文献 · Prog Retin Eye Res · 2023-02-08

本文综述眼部淋巴管或类淋巴管结构在多种眼病发病机制中的作用及其分子机制,涵盖角膜新生淋巴管、眼表疾病、眼肿瘤转移及施莱姆管与青光眼的关系,并讨论基于此的当前与未来治疗选择;临床前数据提出促移植存活、抑转移、减炎症、治青光眼的新概念,早期临床试验初步显示移植前角膜淋巴管消退策略促移植存活的首个成功。

要点

  • 眼部曾被视为无淋巴管器官,现已知淋巴管或类淋巴管结构参与多种眼内及眼周病变。
  • 综述覆盖角膜淋巴管生成机制、眼表疾病、眼肿瘤转移及施莱姆管在青光眼中的新作用。
  • 临床前数据提出促移植存活、抑肿瘤转移、减眼表炎症、治青光眼的新治疗概念。

核心结论

  • 识别淋巴管生成相关分子机制及新型调节因子将有助于未来开发针对病理性淋巴管生成相关眼病的新的治疗靶点。

研究设计与样本

  • 本文为综述,旨在概述眼部淋巴管的致病作用、相应分子机制并讨论基于此的当前与未来治疗选择。

主要发现

  • 综述概述健康眼表的血管解剖及促成角膜(淋巴)血管生成特许的分子机制。
  • 综述呈现炎症或创伤等触发的角膜病理性新生血管化过程中的细胞与分子机制当前认识。
  • 综述呈现淋巴管在干眼病、角膜移植排斥、眼部移植物抗宿主病、过敏及翼状胬肉等眼表病变中的作用。
  • 综述呈现淋巴管参与眼部肿瘤与转移及施莱姆管类淋巴管结构在青光眼中的新作用。
  • 临床前数据提出促移植存活、抑眼部肿瘤转移、减眼表炎症及治青光眼的新治疗概念。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Historically, the eye has been considered as an organ free of lymphatic vessels. In recent years, however, it became evident, that lymphatic vessels or lymphatic-like vessels contribute to several ocular pathologies at various peri- and intraocular locations. The aim of this review is to outline the pathogenetic role of ocular lymphatics, the respective molecular mechanisms and to discuss current and future therapeutic options based thereon. We will give an overview on the vascular anatomy of the healthy ocular surface and the molecular mechanisms contributing to corneal (lymph)angiogenic privilege. In addition, we present (i) current insights into the cellular and molecular mechanisms occurring during pathological neovascularization of the cornea triggered e.g. by inflammation or trauma, (ii) the role of lymphatic vessels in different ocular surface pathologies such as dry eye disease, corneal graft rejection, ocular graft versus host disease, allergy, and pterygium, (iii) the involvement of lymphatic vessels in ocular tumors and metastasis, and (iv) the novel role of the lymphatic-like structure of Schlemm's canal in glaucoma. Identification of the underlying molecular mechanisms and of novel modulators of lymphangiogenesis will contribute to the development of new therapeutic targets for the treatment of ocular diseases associated with pathological lymphangiogenesis in the future. The preclinical data presented here outline novel therapeutic concepts for promoting transplant survival, inhibiting metastasis of ocular tumors, reducing inflammation of the ocular surface, and treating glaucoma. Initial data from clinical trials suggest first success of novel treatment strategies to promote transplant survival based on pretransplant corneal lymphangioregression.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Clahsen T, Hadrian K, Notara M, et al. The novel role of lymphatic vessels in the pathogenesis of ocular diseases. Prog Retin Eye Res. 2023. PMID: 36759312. doi:10.1016/j.preteyeres.2022.101157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。